MedTrace Logo

Epigenetics and Gut Microbiota in Children With Epilepsy

NCT04063007 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-09-22

No results posted yet for this study

Summary

The ketogenic diet is a high-fat, low-carbohydrate diet used in the treatment of epilepsy. The diet can be an efficient treatment option in children with drug resistant epilepsy, with more than 50 % seizure reduction in about 40- 70 % of the patients. However, there is still a lack of knowledge regarding the mechanisms of action, how will respond to the treatment and potential adverse effects.

Conditions

Interventions

OTHER

Ketogenic diet

The patients follow the ordinary treatment protocol for ketogenic diet

Sponsors & Collaborators

  • Norwegian University of Life Sciences

    collaborator OTHER

  • University of Oslo

    collaborator OTHER

  • Lund University

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Kaja K Selmer, PhD · Oslo University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-15
Primary Completion
2022-11-01
Completion
2022-11-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04063007 on ClinicalTrials.gov